Menu
GeneBe

MEIS2

Meis homeobox 2, the group of TALE class homeoboxes and pseudogenes|MicroRNA protein coding host genes

Basic information

Region (hg38): 15:36889203-37101299

Links

ENSG00000134138NCBI:4212OMIM:601740HGNC:7001Uniprot:O14770AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies (Moderate), mode of inheritance: AD
  • cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies (Definitive), mode of inheritance: AD
  • syndromic intellectual disability (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cleft palate, cardiac defects, and impaired intellectual developmentADCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early identifcation and managementCardiovascular; Craniofacial; Musculoskeletal; Neurologic24678003; 25712757; 26561393; 27225850

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MEIS2 gene.

  • Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies (71 variants)
  • not provided (33 variants)
  • Inborn genetic diseases (18 variants)
  • MEIS2-related condition (2 variants)
  • not specified (1 variants)
  • MEIS2-related disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MEIS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
21
clinvar
4
clinvar
27
missense
2
clinvar
10
clinvar
36
clinvar
2
clinvar
3
clinvar
53
nonsense
5
clinvar
1
clinvar
1
clinvar
7
start loss
0
frameshift
1
clinvar
3
clinvar
4
clinvar
8
inframe indel
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
2
clinvar
1
clinvar
1
clinvar
4
splice region
2
2
4
non coding
2
clinvar
5
clinvar
3
clinvar
10
Total 10 16 47 28 10

Variants in MEIS2

This is a list of pathogenic ClinVar variants found in the MEIS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-36892180-G-A Inborn genetic diseases Uncertain significance (Apr 20, 2021)2411674
15-36892191-C-T Inborn genetic diseases Likely benign (Oct 26, 2021)2292159
15-36892192-A-G Inborn genetic diseases Uncertain significance (Oct 26, 2021)3125280
15-36892242-C-G Inborn genetic diseases Uncertain significance (Sep 19, 2022)2312620
15-36892266-G-T Uncertain significance (Feb 01, 2023)2645153
15-36892283-C-T Inborn genetic diseases Uncertain significance (Sep 29, 2022)2314412
15-36892334-T-C Inborn genetic diseases Uncertain significance (Dec 01, 2022)3125278
15-36892335-T-TG Inborn genetic diseases Uncertain significance (Jul 23, 2021)2232077
15-36892345-T-C MEIS2-related disorder Benign/Likely benign (Dec 20, 2023)2645154
15-36892437-G-C Inborn genetic diseases Uncertain significance (Oct 18, 2021)3125277
15-36892441-C-G Inborn genetic diseases Likely benign (Jul 26, 2022)2303524
15-36892450-C-T Inborn genetic diseases Uncertain significance (Feb 15, 2023)2473365
15-36892460-C-A Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Uncertain significance (Dec 16, 2021)2581030
15-36894792-T-C Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Benign (Jul 10, 2023)2036593
15-36894795-C-T Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Uncertain significance (Mar 13, 2022)2418575
15-36894796-C-A Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Uncertain significance (Jul 10, 2023)2954754
15-36894803-CT-C Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Uncertain significance (Mar 31, 2022)1805395
15-36894807-T-C Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Uncertain significance (Oct 05, 2023)2832170
15-36895133-C-T Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Likely benign (Mar 27, 2021)1658294
15-36895134-G-A Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Likely benign (Apr 21, 2022)2055374
15-36895169-T-G Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Uncertain significance (Sep 08, 2021)854177
15-36895183-TC-T Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Uncertain significance (May 06, 2021)1804981
15-36895233-T-C Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Likely benign (Dec 28, 2022)2956916
15-36895237-C-T not specified Uncertain significance (Dec 02, 2022)1878354
15-36895255-AG-A Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies Uncertain significance (Sep 14, 2018)1334074

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MEIS2protein_codingprotein_codingENST00000561208 12212099
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.000617125642051256470.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.461712880.5930.00001453167
Missense in Polyphen1976.7820.24745928
Synonymous-0.2391131101.030.00000657901
Loss of Function4.52125.70.03890.00000126284

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001870.0000176
Middle Eastern0.000.00
South Asian0.00006540.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in transcriptional regulation. Binds to HOX or PBX proteins to form dimers, or to a DNA-bound dimer of PBX and HOX proteins and thought to have a role in stabilization of the homeoprotein-DNA complex. Isoform 3 is required for the activity of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element; MEIS2 is not involved in complex DNA-binding. Probably in complex with PBX1, is involved in transcriptional regulation by KLF4. Isoform 3 and isoform 4 can bind to a EPHA8 promoter sequence containing the DNA motif 5'-CGGTCA-3'; in cooperation with a PBX protein (such as PBX2) is proposed to be involved in the transcriptional activation of EPHA8 in the developing midbrain. May be involved in regulation of myeloid differentiation. Can bind to the DNA sequence 5'-TGACAG-3'in the activator ACT sequence of the D(1A) dopamine receptor (DRD1) promoter and activate DRD1 transcription; isoform 5 cannot activate DRD1 transcription. {ECO:0000269|PubMed:10764806, ECO:0000269|PubMed:11279116, ECO:0000269|PubMed:21746878}.;
Disease
DISEASE: Cleft palate, cardiac defects, and mental retardation (CPCMR) [MIM:600987]: An autosomal dominant disease characterized by multiple congenital malformations, mild-to-severe intellectual disability with poor speech, and delayed psychomotor development. Congenital malformations include heart defects, cleft lip/palate, distally-placed thumbs and toes, and cutaneous syndactyly between the second and third toes. {ECO:0000269|PubMed:24678003, ECO:0000269|PubMed:25712757, ECO:0000269|PubMed:27225850}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.163

Intolerance Scores

loftool
0.0910
rvis_EVS
-0.4
rvis_percentile_EVS
26.53

Haploinsufficiency Scores

pHI
0.621
hipred
Y
hipred_score
0.768
ghis
0.548

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.977

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Meis2
Phenotype
vision/eye phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; liver/biliary system phenotype; embryo phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
meis2a
Affected structure
cranial cartilage
Phenotype tag
abnormal
Phenotype quality
mislocalised

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;eye development;transcription by RNA polymerase II;visual learning;response to mechanical stimulus;pancreas development;negative regulation of myeloid cell differentiation;positive regulation of mitotic cell cycle;positive regulation of transcription by RNA polymerase II;response to growth factor;positive regulation of cardiac muscle myoblast proliferation
Cellular component
nucleus;perinuclear region of cytoplasm
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription coregulator activity;transcription corepressor activity;protein binding;transcription factor binding